Accretive Health
AH
AH was delisted on the 14th of March, 2014.
5 hedge funds and large institutions have $6.52M invested in Accretive Health in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
65% less capital invested
Capital invested by funds: $18.5M → $6.52M (-$11.9M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$428K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$11.2M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
-$490K |
| 3 |
Neuberger Berman Group
New York
|
-$92.3K |
AH Hedge Fund Activity: Q4 2016 in Review
5 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q4 2016, worth a combined $6.52M — down 65% from $18.5M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AH and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Perceptive Advisors, adding an estimated $428K. The largest seller was Paradigm Capital Management Inc, exiting entirely with an estimated $11.2M sold.
- 5 institutional investors held Accretive Health (AH) as of Q4 2016, down from 6 in Q3 2016.
- Funds reported $6.52M of Accretive Health stock for Q4 2016, down 65% quarter-over-quarter.
- 0 funds opened new Accretive Health positions in Q4 2016 and 1 closed out, a net change of -1 holder.
- The largest Accretive Health buyer in Q4 2016 was Perceptive Advisors, an estimated $428K added.
- The largest Accretive Health seller in Q4 2016 was Paradigm Capital Management Inc, an estimated $11.2M sold.
Based on aggregated 13F filings for Q4 2016.